http://purl.org/np/RAUrxzwrvh... RAUrxzwrvh

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://www.w3.org/ns/prov#wasAttributedTo wasAttributedTo

https://orcid.org/0000-0002-3668-2627 Elif Ozkan

Elif Ozkan

2022-10-13T12:08:46.697Z

http://purl.org/np/RAUrxzwrvh... RAUrxzwrvh

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://www.w3.org/ns/prov#generatedAtTime generatedAtTime

2022-10-13T12:08:46.697156

Elif Ozkan

2022-10-13T12:08:46.697Z

http://purl.org/np/RAUrxzwrvh... RAUrxzwrvh

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://www.w3.org/ns/prov#wasQuotedFrom wasQuotedFrom

Indevimab is used only with casirivimab to prevent COVID-19 from laboratory-confirmed SARS-CoV-2 infection in patients aged 12 years of age and older who weigh at least 40 kg. Treatment is reserved for patients who are at high risk for progressing to require hospitalization or severe treatment. This combination may only be administered by intravenous infusion in healthcare settings with immediate access to treatment.

Elif Ozkan

2022-10-13T12:08:46.697Z